Portland, OR, July 26, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Pain Management Devices Market garnered $3.68 billion in 2020, and is expected to reach $5.76 billion by 2028, manifesting a CAGR of 6.3% from 2021 to 2028. The report offers an extensive analysis of changing market trends, key segments, regional scenarios, top investment pockets, value chain, and competitive landscape.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/169
Increase in prevalence of chronic diseases, rise in R&D investments, and launch of innovative products drive the growth of the global pain management devices market. However, hypersensitivity reactions and postoperative infections caused by use of these devices hinder their adoption, which in turn, restricts the market growth. On the other hand, untapped potential in developing countries would present new opportunities in the coming years.
Covid-19 Scenario:
- Many clinics and pain management services were open to the public for a limited period to avoid cross-contamination. A lot of hospitals & clinics have witnessed a considerable drop in the number of patient visits.
- Most of the chronic pain facilities were considered non-urgent. Outpatient and elective interventional procedures were stopped or limited during the Covid-19 pandemic to minimize client contact and the spread of the virus.
- Owing to considerable rise in Covid-infected patients in hospitals, the staff was allocated to take care of patients in Covid wards. This reduced the manpower for pain management services.
The report offers detailed segmentation of the global pain management devices market based on type, application, and region.
Based on type, the neuromodulation and neurostimulation devices segment contributed to the largest share in 2020, holding more than three-fifths of the total market share, and is estimated to maintain its leadership status during the forecast period. However, the analgesic infusion pumps segment is expected to maintain the largest CAGR of 7.7% from 2021 to 2028.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/169
Based on application, the neuropathic pain segment held the highest market share, accounting for nearly one-third of the global pain management devices market in 2020, and is expected to maintain its lead position during the forecast period. However, the cancer pain segment is projected to portray the fastest CAGR of 7.8% from 2021 to 2028.
Based on region, North America accounted for the highest share in 2020, holding more than two-fifths of the total market share, and is estimated to continue its dominant share in terms of revenue by 2028. However, Asia-Pacific is projected to manifest the highest CAGR of 7.9% during the forecast period.
Leading players of the global pain management devices market analyzed in the research include Abbott Laboratories, Baxter International Inc., B Braun Melsungen AG, DJO Global LLC., Boston Scientific Corp., Kimberly Clark Corporation, Johnson & Johnson (Codman And Shurtleff, Inc.), Pfizer, Inc., Medtronic Plc., and Stryker Corp.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Similar Reports:
Pain Management Drugs Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Non-opioid Pain Patch Market - Global Opportunity Analysis and Industry Forecast, 2019-2028
Topical Pain Relief Cream Market - Global Opportunity Analysis and Industry Forecast, 2019-2028
Cancer Pain Market - Global Opportunity Analysis and Industry Forecast, 2019–2028
Chronic Pain Market - Global Opportunity Analysis and Industry Forecast, 2019–2028
U.S. Pain Management Drugs Market - Global Opportunity Analysis and Industry Forecast, 2019–2028
Pulse Oximeters Market - Global Opportunity Analysis and Industry Forecast, 2019–2028
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.